Variables | Dapagliflozin (n = 14) | DPP-4 inhibitors (n = 15) | Change difference between groups p value |
---|---|---|---|
Mean change (95% CI) | Mean change (95% CI) | ||
HbA1c (%) | 0.48 (0.17 to 0.79)††| 0.24 (−0.13 to 0.61) | 0.30 |
Glycated albumin (%)a | 1.04 (−0.14 to 2.21) | 0.55 (−0.91 to 2.01) | 0.58 |
Body mass index (kg m−2) | −0.90 (−1.42 to −0.39)††| 0.12 (−0.12 to 0.36) | 0.001 |
Systolic BP (mmHg)b | −2.8 (−11.5 to 5.8) | 4.5 (−5.7 to 14.6) | 0.25 |
Diastolic BP (mmHg)b | 4.1 (−3.2 to 11.4) | 2.0 (−2.9 to 6.9) | 0.61 |
Hemoglobin (g dL−1)a | 0.44 (0.05 to 0.83)†| 0.01 (−0.43 to 0.47) | 0.13 |
Hematocrit (%)a | 1.61 (0.46 to 2.77)†| −0.23 (−1.61 to 1.15) | 0.04 |
ALT (U L−1) | −2.0 (−26.0 to 6.0) | 1.0 (−4.0 to 11.0) | 0.03‡ |
Uric acid (mg dL−1) | −0.54 (−1.10 to 0.03) | 0 (−0.37 to 0.32) | 0.11 |
Estimated GFR [mL min−1 (1.73 m2)−1] | 1.3 (−11.7 to 9.0) | 3.0 (−4.9 to 13.6) | 0.42‡ |
Log UACRa | −0.16 (−0.32 to 0)†| 0.04 (−0.10 to 0.17) | 0.05 |